Détention brevets de la classe A61K 31/4535

Brevets de cette classe: 714

Historique des publications depuis 10 ans

42
42
48
49
48
55
42
42
40
47
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Propriétaires principaux

Proprétaire
Total
Cette classe
Bridge Pharma, Inc.
32
20
Novartis AG
10707
13
Ovid Therapeutics Inc
167
11
Duke University
3092
10
Vertical Pharmaceuticals, LLC
44
10
Sen-jam Pharmaceutical Inc.
18
10
Astellas Pharma Inc.
1071
9
Dompé Farmaceutici S.p.A.
273
9
Takeda Pharmaceutical Company Limited
2704
8
Pharos iBio Co., Ltd.
14
8
Johnson & Johnson Vision Care, Inc.
1180
7
The Trustees of the University of Pennsylvania
4366
6
Alectos Therapeutics Inc.
49
6
Florida State University Research Foundation, Inc.
773
6
Serina Therapeutics, Inc.
42
6
The United States of America, as represented by the Secretary, Department of Health and Human Services
2886
6
University of Pittsburgh - Of the Commonwealth System of Higher Education
3189
6
Bristol-myers Squibb Company
4840
5
AstraZeneca AB
2872
5
Janssen Pharmaceutica N.V.
3367
5
Autres propriétaires 548